View from Brussels

Apr 01, 2015
Applied Clinical Trials
Media rebuke of Europe’s Innovative Medicines Initiative thrusts debate into the public arena.
Feb 01, 2015
Applied Clinical Trials
While such discussions have advanced in Europe, two key omissions from the dialogue may limit any real changes.
Jan 02, 2015
Applied Clinical Trials
Patients in Europe have been increasingly vocal in their demands for engagement in drug development and regulatory processes—and they have been increasingly effective.
Dec 01, 2014
Applied Clinical Trials
In a health policy world where competition for profile is tough, a vacuum at the top is a serious disadvantage.
Oct 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Reshuffling to heavily impact life sciences policy in Europe.
Jun 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Claims of success for pharmacovigilance are under question, but hopes are higher for new clinical trials rules.
Apr 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
The advent of new drugs for tuberculosis is posing some interesting challenges for regulators in Europe.
Feb 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
The European Union has a new research program, but will it help, or hinder, clinical trials?
Dec 27, 2013
Applied Clinical Trials
By Applied Clinical Trials Editors
The disengagement of major drug firms is described as "a type of market failure" in a briefing paper published last month by the UK think-tank Chatham House.
Dec 01, 2013
Applied Clinical Trials
By Applied Clinical Trials Editors
Global action and collaboration is needed to tackle the threat of antibiotic-resistant diseases.
native1_300x100
lorem ipsum